Autopsy report · NCT01175668
Clonidine for Neonatal Abstinence Syndrome Study
Cause of deathRegulatory or ethics
“Based on the planned interim analysis results at 50% recruitment, after IRB reviewed the results, further enrollment was stopped.”
Life of this trial
- Ran for about 2 years 3 months before it stopped.
- 68 participants enrolled.
- Results were posted on the registry 1 year 3 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Baystate Medical Center
- Sponsor type
- University, hospital or other
- Conditions
- Neonatal Abstinence Syndrome
- Interventions
- Clonidine; Phenobarbital
- Participants
- 68
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Heliox-Powered Albuterol Therapy in the Treatment of Children Admitted With Acute Asthma Exacerbation
“Study was stopped after interim analysis and slow enrollment.” - Impact of Early Diagnosis and Treatment of OSA on Hospital Readmission in Hospitalized COPD Patients
“The study was withdrawn prior to initiation. The protocol was submitted for IRB review but was not approved. No participants were enrolled.” - Exhaled Breath Condensate pH in Patients With Cough Caused by Gastroesophageal Reflux
“IRB approval not renewed/approval lapsed. Prior status: insufficient enrollment; study suspended pending analysis” - CPAP Population Management
“The study was withdrawn prior to initiation. The protocol was submitted for IRB review but was not approved, and no participants were enrolled.” - A Surgical Approach to the Management of Type II Diabetes Mellitus in Patients With a BMI Between 25-35 kg/m2
“IRB temporarily halted enrollment”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.